Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-08 4:15 pm Sale |
2023-05-04 | 13D | Absci Corporation ABSI |
Casdin Capital, LLC | 4,448,260 4.800% |
-1,085,000 (-19.61%) |
Filing History |
| 2023-03-20 4:22 pm Sale |
2023-03-16 | 13D | Absci Corporation ABSI |
Casdin Capital, LLC | 5,533,260 6.000% |
-940,000 (-14.52%) |
Filing History |
| 2023-02-13 9:36 pm Sale |
2022-12-31 | 13G | DermTech, Inc. DMTKQ |
Casdin Capital, LLC | 0 0.000% |
-1,745,000 (Position Closed) |
Filing History |
| 2023-02-13 9:34 pm Sale |
2022-12-31 | 13G | Tango Therapeutics, Inc. TNGX |
Casdin Capital, LLC | 0 0.000% |
-5,487,910 (Position Closed) |
Filing History |
| 2023-02-13 9:34 pm Sale |
2022-12-31 | 13G | Invitae Corporation NVTAQ |
Casdin Capital, LLC | 9,038,388 3.720% |
-3,165,281 (-25.94%) |
Filing History |
| 2023-02-13 9:31 pm Sale |
2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Casdin Capital, LLC | 0 0.000% |
-3,901,589 (Position Closed) |
Filing History |
| 2023-02-13 9:30 pm Sale |
2022-12-31 | 13G | Codexis, Inc. CDXS |
Casdin Capital, LLC | 0 0.000% |
-4,330,000 (Position Closed) |
Filing History |
| 2023-02-13 9:27 pm Sale |
2022-12-31 | 13G | Verve Therapeutics, Inc. VERV |
Casdin Capital, LLC | 2,290,571 3.700% |
-847,596 (-27.01%) |
Filing History |
| 2023-02-13 11:53 am Sale |
2023-02-08 | 13D | Absci Corporation ABSI |
Casdin Capital, LLC | 6,473,260 7.000% |
-1,245,333 (-16.13%) |
Filing History |
| 2023-01-10 4:48 pm Sale |
2023-01-05 | 13G | MaxCyte, Inc. MXCT |
Casdin Capital, LLC | 9,220,000 9.020% |
-4,751,334 (-34.01%) |
Filing History |
| 2022-12-07 1:51 pm Unchanged |
2022-12-05 | 13D | Tenaya Therapeutics, Inc. TNYA |
Casdin Capital, LLC | 6,427,200 9.900% |
0 (Unchanged) |
Filing History |
| 2022-11-29 5:11 pm Purchase |
2022-11-23 | 13D | EQRx, Inc. EQRX |
Casdin Capital, LLC | 56,297,042 13.000% |
56,297,042 (New Position) |
Filing History |
| 2022-11-28 4:06 pm Purchase |
2022-11-17 | 13D | Tenaya Therapeutics, Inc. TNYA |
Casdin Capital, LLC | 6,427,200 9.900% |
2,840,382 (+79.19%) |
Filing History |
| 2022-10-11 2:09 pm Sale |
2022-10-01 | 13D | Century Therapeutics, Inc. IPSC |
Casdin Capital, LLC | 3,222,940 5.500% |
-23,184 (-0.71%) |
Filing History |
| 2022-07-20 6:54 pm Unchanged |
2022-07-08 | 13D | Absci Corporation ABSI |
Casdin Capital, LLC | 7,718,593 8.300% |
0 (Unchanged) |
Filing History |
| 2022-04-08 5:07 pm Purchase |
2022-04-04 | 13D | Standard BioTools Inc. LAB |
Casdin Capital, LLC | 37,582,346 32.740% |
37,582,346 (New Position) |
Filing History |
| 2022-02-14 09:27 am Purchase |
2021-12-31 | 13G | Verve Therapeutics, Inc. VERV |
Casdin Capital, LLC | 3,138,167 6.500% |
100,000 (+3.29%) |
Filing History |
| 2022-02-11 10:00 pm Purchase |
2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Casdin Capital, LLC | 3,901,589 6.640% |
555,554 (+16.60%) |
Filing History |
| 2022-02-11 9:57 pm Purchase |
2021-12-31 | 13G | DermTech, Inc. DMTKQ |
Casdin Capital, LLC | 1,745,000 5.870% |
375,000 (+27.37%) |
Filing History |
| 2022-02-11 9:56 pm Sale |
2021-12-31 | 13G | Invitae Corporation NVTAQ |
Casdin Capital, LLC | 12,203,669 5.390% |
-94,369 (-0.77%) |
Filing History |